Skip to main content
. 2017 Jul 31;2(3):259–269. doi: 10.1016/j.adro.2017.07.009

Figure 1.

Figure 1

(A) Overall survival in the 3 patient cohorts: Trimodality (dark solid line), unplanned bimodality (dark dashed line), and planned bimodality (light dashed line). Hazard ratio (HR) comparing the trimodality and unplanned bimodality cohorts: HR, 0.688; 95% CI, 0.595-0.796; P < .001. Inset shows overall survival as a function of surgery type (lobectomy: dark dashed line; pneumonectomy: light dashed line) in patients who underwent trimodality treatment: P = .513; (B) Intention-to-treat overall survival curves comparing all trimodality patients (unplanned bimodality+trimodality; dark solid line) and planned bimodality cohort (light solid line). HR, 0.643; 95% CI, 0.505-0.819; P < .001.